To view this email as a web page, click here.
 
Selexipag Delays PAH Progression in Patients with Connective Tissue Disease
Results of a subgroup analysis from the GRIPHON trial are promising for this hard-to-treat population.
At-a-glance slide show review.
 
Exercise-induced Hypertension: Benign or Predictive?
T or F: A delayed decline of SBP during exercise recovery predicts severe coronary artery disease.
Try the rest of this exercise challenge.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.